REMEVi, checked
Is REMEVi legit? What to verify before you pay
This page is written by REMEVi about REMEVi. We have a commercial interest in your choice, so every claim below points to a source outside our control where one exists.
REMEVi is a real telehealth company: a Nevada LLC in Las Vegas, certified by LegitScript (ID 50384507; registry checked September 17, 2026). Licensed providers in 49 states and DC — not Louisiana — review every request, and if you are not prescribed, you get a full refund. Each fact below links to where you can check it.
Is REMEVi legit?
Quick answer: REMEVi is a Nevada company, LegitScript-certified (ID 50384507), whose prescribers are licensed where you live. You can check each fact yourself.
REMEVi is REMEVi LLC, a Nevada limited liability company with its business office at 1635 Village Center Circle, Suite 250, Las Vegas, NV 89134. You can reach a person at (702) 352-4746 or care@remevihealth.com, in English or Spanish.
LegitScript is an independent company that certifies healthcare businesses selling online. Its standards cover practitioner credentials, applicable laws, prescription practices, privacy, transparency and advertising, and certified businesses are monitored after approval. On September 17, 2026, LegitScript’s public registry listed remevihealth.com as Certified. Check it again before you rely on it — what the certification covers, and what it does not.
Prescribing decisions are made by independent clinicians in the OpenLoop network who hold a license in the state where you receive care. Their credentials are verified to the NCQA standard (NCQA-verified credentialing; REMEVi itself is not NCQA-accredited). Prescriptions are prepared by state-licensed 503A compounding pharmacies, listed by name on our pharmacies page.
Two honest caveats. REMEVi is a young company: it began offering care in 2026, so it has a short track record. And the medication it offers is compounded, which means it is not FDA-approved and is not a generic of any brand-name drug.
| Fact | Where to check it | Last checked by us |
|---|---|---|
| LegitScript certification, ID 50384507 | LegitScript’s public registry | September 17, 2026 |
| Company and business address | REMEVi LLC, 1635 Village Center Circle, Suite 250, Las Vegas, NV 89134 — About REMEVi | October 9, 2026 |
| Pharmacies that prepare prescriptions | RedRock Pharmacy, Health Warehouse, Precision Medicine, Triad Rx | July 2026 |
| Google rating | 5.0 on REMEVi’s Google Business Profile | September 4, 2026 |
| Prices and plan terms | Published plan table | October 9, 2026 |
| Refund if not prescribed | Cancellation & Refund Policy | October 9, 2026 |
What does REMEVi cost?
Quick answer: Semaglutide: From $159 per 4 weeks on the 24-week plan · or $199 every 4 weeks, cancel any time. One price at every dose, no membership fee.
Compounded semaglutide: From $159 per 4 weeks on the 24-week plan · or $199 every 4 weeks, cancel any time. Compounded tirzepatide: From $225 per 4 weeks on the 24-week plan · or $269 every 4 weeks, cancel any time. Your dose goes up, your price doesn't: each plan has one price at every dose and every renewal of that plan.
There is no membership fee and no separate visit fee. Lab tests required by your clinician for the GLP-1 program are included in your plan price. Shipping is part of the plan price. REMEVi does not bill insurance; HSA and FSA cards are accepted.
| Plan | Semaglutide | Tirzepatide |
|---|---|---|
| Every 4 weeks (month-to-month) | $199 every 4 weeks | $269 every 4 weeks |
| 12-week plan (paid upfront) | $507 upfront = $169 per 4 weeks | $699 upfront = $233 per 4 weeks |
| 24-week plan (paid upfront) | $954 upfront = $159 per 4 weeks | $1,350 upfront = $225 per 4 weeks |
Each plan has one price at every dose and every renewal of that plan. No membership fee. Lab tests required by your clinician for the GLP-1 program are included in your plan price. Billing is every 4 weeks (28 days), not every calendar month.
What happens if I’m not prescribed?
Quick answer: You get a full refund. A licensed provider reviews your answers first, and you are only treated if they prescribe.
You answer the online questionnaire and pay for the plan you choose. A provider licensed in your state reviews your answers and may ask for a video visit when your answers or your state’s rules call for one. If the provider does not prescribe, the payment is refunded in full.
You can cancel future renewals without a cancellation fee. Prepaid terms are paid in advance; refund eligibility is governed by the Cancellation & Refund Policy. Read the policy.
What do REMEVi reviews say?
Quick answer: REMEVi’s Google rating was 5.0 when we checked on September 4, 2026. Read the reviews on the live Google profile.
Google is the review platform REMEVi shows. The rating was 5.0 on September 4, 2026; it can change, so read the reviews themselves on REMEVi’s Google Business Profile.
Our reviews page explains how reviews are collected and shown: per platform, never blended, never edited, and never shown under a “verified” label after translation. REMEVi does not pay for reviews or ask only happy patients.
What doesn’t REMEVi do?
Quick answer: REMEVi does not bill insurance, offer in-person visits, serve Louisiana or sell brand-name drugs, and its compounded medication is not FDA-approved.
Knowing what a provider will not do is part of checking it. Plainly:
- No insurance billing. REMEVi is self-pay. If your plan covers a brand-name medicine, compare your real copay first.
- No in-person visits. Care is online: a questionnaire, messages and, when needed, a video visit. The Las Vegas address is a business office, not a clinic.
- No Louisiana. Compounded semaglutide and tirzepatide are not offered to Louisiana residents.
- No brand-name drugs. REMEVi does not sell Ozempic®, Wegovy®, Mounjaro® or Zepbound®. Those names are mentioned here only to orient you.
- Not FDA-approved medication. Compounded medications are prepared by licensed pharmacies for an individual prescription; they are not FDA-approved and not reviewed by the FDA for safety or effectiveness.
- No guaranteed prescription. A provider decides. If they do not prescribe, you are refunded.
How do I check if a telehealth GLP-1 provider is legit?
Quick answer: Check six things: the prescriber’s state license, LegitScript, the pharmacy’s license, published prices, refund terms and a real address.
Use this list on any provider, including us. Each step takes a few minutes.
- The prescriber’s state license. Ask for the clinician’s full name and license number, then look it up on your state’s medical or nursing board site (DocInfo for MDs and DOs, Nursys for nurse practitioners).
- LegitScript. Search the website’s exact domain on LegitScript’s registry. A seal image alone proves nothing; the registry entry does.
- The pharmacy’s license. The provider should name the pharmacy. Check its license with that state’s board of pharmacy, and read the FDA’s note on compounded drugs.
- Published prices. You should be able to see the first charge, the renewal charge and whether the price rises with dose — before you enter a card.
- Refund terms in writing. What happens to your money if you are not prescribed, and when an order becomes non-refundable.
- A real address and a phone that answers. Call it. A business that can’t be reached before you pay is harder to reach after.
To see how other programs publish these details, read our dated comparison of GLP-1 telehealth programs.
Who should not apply to REMEVi?
Quick answer: People who are under 18, pregnant or breastfeeding, or who have certain conditions — such as medullary thyroid cancer or MEN2 — cannot be prescribed through REMEVi.
The online questionnaire stops a request when any of these applies. The list mirrors those questions; it is not medical advice, and a licensed provider makes the final decision for everyone else.
- Under 18
- Pregnant, possibly pregnant or trying to become pregnant, or breastfeeding
- A personal or family history of medullary thyroid cancer or MEN2
- History of, or current, pancreatitis
- Type 1 diabetes, or type 2 diabetes on insulin or with an A1c above 10%
- A severe stomach or intestinal condition (gastroparesis, blockage or bowel resection)
- Severe kidney disease (on or about to start dialysis) or severe liver disease, including cirrhosis
- Diabetic retinopathy, optic-nerve damage, macular degeneration or blindness
- Cancer that is active, in treatment, or cancer-free for less than 5 years (cured non-melanoma skin cancer excepted)
- An organ transplant with anti-rejection medication
- Living in Louisiana, where REMEVi does not offer its compounded program
If something on this list applies to you, talk with your own healthcare provider about options.
Frequently asked questions
Is REMEVi a real company?
Yes. REMEVi is REMEVi LLC, a Nevada company at 1635 Village Center Circle, Suite 250, Las Vegas, NV 89134, reachable at (702) 352-4746. Its website is LegitScript-certified (ID 50384507).
Is REMEVi’s medication FDA-approved?
No. REMEVi offers compounded semaglutide and tirzepatide prepared by state-licensed 503A pharmacies. Compounded medications are not FDA-approved. LegitScript certification is not FDA approval.
Who prescribes at REMEVi?
Independent licensed providers in the OpenLoop network, licensed in the state where you receive care. They decide whether a prescription is appropriate.
Does REMEVi take insurance?
No. REMEVi is self-pay and does not bill insurance. HSA and FSA cards are accepted.
Can I get care in Spanish?
Yes. The questionnaire, messages and support are available in English or Spanish, and you can switch at any time.
See whether REMEVi fits you
Compounded semaglutide: From $159 per 4 weeks on the 24-week plan · or $199 every 4 weeks, cancel any time.
Compounded tirzepatide: From $225 per 4 weeks on the 24-week plan · or $269 every 4 weeks, cancel any time.
Each plan has one price, the same at every dose and every renewal, with no membership fee. Compounded medication is not FDA-approved.
Not prescribed? Full refund. Cancel anytime.
Corrections: care@remevihealth.com — we update competitor facts when they change.